Valuation: CapsoVision, Inc.

Market Cap 299M 262M 241M 223M 423M 28.54B 430M 2.89B 1.13B 14.06B 1.12B 1.1B 48.34B P/E 2026 *
-11.5x
P/E 2027 * -14.3x
Enterprise Value 299M 262M 241M 223M 423M 28.54B 430M 2.89B 1.13B 14.06B 1.12B 1.1B 48.34B EV / Sales 2026 *
19.2x
EV / Sales 2027 * 13.9x
Free-Float
67.91%
Yield 2026 *
-
Yield 2027 * -
1 day+3.81%
1 week-17.72%
Current month-20.98%
1 month-13.06%
3 months-4.16%
6 months-1.80%
Current year-43.97%
1 week 5.62
Extreme 5.62
7.29
1 month 5.62
Extreme 5.62
7.77
Current year 4.5
Extreme 4.5
11.37
1 year 3.43
Extreme 3.4341
15.37
3 years 3.43
Extreme 3.4341
15.37
5 years 3.43
Extreme 3.4341
15.37
10 years 3.43
Extreme 3.4341
15.37
Manager TitleAgeSince
Chief Executive Officer 69 2024-10-31
Director of Finance/CFO 52 -
Corporate Officer/Principal - 2022-02-28
Director TitleAgeSince
Chairman 74 2024-12-31
Director/Board Member 66 2025-06-30
Director/Board Member 62 2025-06-30
Date Insider Type Main position Quantity % Market Cap.
06-30Other

Director

0 0%
06-30Free

Director

1,710 0.0034%
06-29Fiscal year

Chairman

4,044 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
+3.81%-17.72%+31.07% - 299M
+0.80%+3.88%-13.15%-23.05% 13.18B
-8.49%-11.77%+66.32%+3.87% 4.59B
-0.86%-3.73%+68.84%+113.58% 1.24B
+3.33%-3.12%-34.28%-62.90% 1.2B
+5.13%+0.18%-37.64%-46.66% 1.13B
+2.20%-5.30%-47.13% - 880M
-0.48%-3.54%+150.76%+138.84% 615M
+1.68%-1.45%-54.05%+222.83% 263M
+12.01%+30.68%+15.51%+53.02% 144M
Average +1.91%-0.83%+14.63%+49.94% 2.35B
Weighted average by Cap. -0.63%-0.45%+7.71%-5.43%

Financials

2026 *2027 *
Net sales 15.58M 13.62M 12.57M 11.61M 22.02M 1.49B 22.39M 150M 58.96M 732M 58.48M 57.21M 2.52B 21.48M 18.78M 17.33M 16M 30.36M 2.05B 30.87M 207M 81.3M 1.01B 80.63M 78.88M 3.47B
Net income -24.59M -21.51M -19.84M -18.32M -34.76M -2.34B -35.35M -237M -93.07M -1.16B -92.31M -90.3M -3.97B -20.36M -17.81M -16.43M -15.17M -28.79M -1.94B -29.27M -196M -77.07M -957M -76.44M -74.78M -3.29B
Net Debt - -
Logo CapsoVision, Inc.
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Employees
99
Date Price Change Volume
26-07-10 US$5.990 +3.81% 87,048
26-07-09 US$5.770 -5.80% 150,561
26-07-08 US$6.125 +8.02% 268,541
26-07-07 US$5.670 -14.22% 367,576
26-07-06 US$6.610 -9.20% 175,356
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.990USD
Average target price
10.00USD
Spread / Average Target
+66.94%

Quarterly revenue - Rate of surprise